1st May 2025 7:00 am |
RNS |
Transaction in Own Shares |
30th Apr 2025 7:05 am |
RNS |
Transaction in Own Shares |
30th Apr 2025 7:00 am |
RNS |
1st Quarter Results |
29th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
28th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
25th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
24th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
23rd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
22nd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
17th Apr 2025 4:13 pm |
RNS |
Blenrep licensed by UK MHRA |
17th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th Apr 2025 7:10 am |
RNS |
Arexvy now ACIP recommended for 50-59 at risk |
17th Apr 2025 7:05 am |
RNS |
GSK 5-in-1 meningitis vaccine recommended in US |
17th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
16th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
15th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
15th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
14th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
11th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
10th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
9th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
8th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
7th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
4th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
3rd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
2nd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
1st Apr 2025 3:30 pm |
RNS |
Total Voting Rights |
1st Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
31st Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
28th Mar 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
28th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
27th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
26th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
25th Mar 2025 4:34 pm |
RNS |
GSK uUTI treatment approved by US FDA |
25th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
24th Mar 2025 4:10 pm |
RNS |
Notice of AGM |
24th Mar 2025 7:05 am |
RNS |
EMA Filing acceptance for Nucala COPD |
24th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
21st Mar 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |